RY 175.68 -0.0512% SHOP 158.4 0.3802% TD 79.39 0.392% ENB 60.27 0.2162% BN 85.2 -1.0338% TRI 225.93 -0.3572% CNQ 47.38 0.7656% CP 106.35 0.6435% CNR 156.78 0.4614% BMO 133.32 0.0826% BNS 79.87 0.4401% CSU 4705.1001 -0.3488% CM 90.43 -0.2977% MFC 44.85 0.3131% ATD 83.17 0.8488% NGT 59.02 0.2378% TRP 67.76 -0.2503% SU 55.71 0.3603% WCN 272.06 0.4542% L 182.13 0.7523%
Company Profile:
Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of various vaccines to prevent serious infectious diseases. The company's recombinant technology platform harnesses the power and speed of genetic engineering to produce immunogenic nanoparticles designed to address urgent global health needs. The company is also evaluating its COVID-19-Influenza Combination vaccine candidate, its quadrivalent influenza investigational vaccine candidate, and an Omicron strain-based vaccine, as well as a bivalent format Omicron-based/original strain-based vaccine.
Summary Table
Stock Price Chart and Technical Summary
Markets are trading in a highly volatile zone currently due to certain macroeconomic and geopolitical tensions prevailing. Therefore, it is prudent to follow a cautious approach while investing.
Note 1: Past performance is not a reliable indicator of future performance.
Note 2: The reference date for all price data, currency, technical indicators, support, and resistance levels is February 16, 2022. The reference data in this report has been partly sourced from REFINITIV.
Disclaimer
The advice given by Kalkine Canada Advisory Services Inc. and provided on this website is general information only and it does not take into account your investment objectives, financial situation and the particular needs of any particular person. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. The website www.kalkine.ca is published by Kalkine Canada Advisory Services Inc. The link to our Terms & Conditions has been provided please go through them. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.
CA 
AU
UK
US
NZ
Please wait processing your request...